The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cannons, J. L.
Right arrow Articles by Watts, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cannons, J. L.
Right arrow Articles by Watts, T. H.
The Journal of Immunology, 2001, 167: 1313-1324.
Copyright © 2001 by The American Association of Immunologists

4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1

Jennifer L. Cannons*, Peggy Lau*, Birinder Ghumman*, Mark A. DeBenedette2,*, Hideo Yagita{dagger}, Ko Okumura{dagger} and Tania H. Watts3,*

* Department of Immunology, University of Toronto, Toronto, Ontario, Canada; and {dagger} Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan

A costimulatory member of the TNFR family, 4-1BB, is expressed on activated T cells. Although some reports have suggested that 4-1BB is primarily involved in CD8 T cell activation, in this report we demonstrate that both CD4 and CD8 T cells respond to 4-1BB ligand (4-1BBL) with similar efficacy. CD4 and CD8 TCR transgenic T cells up-regulate 4-1BB, OX40, and CD27 and respond to 4-1BBL-mediated costimulation during a primary response to peptide Ag. 4-1BBL enhanced proliferation, cytokine production, and CTL effector function of TCR transgenic T cells. To compare CD4 vs CD8 responses to 4-1BBL under similar conditions of antigenic stimulation, we performed MLRs with purified CD4 or CD8 responders from CD28+/+ and CD28-/- mice. We found that CD8 T cells produced IL-2 and IFN-{gamma} in a 4-1BBL-dependent manner, whereas under the same conditions the CD4 T cells produced IL-2 and IL-4. 4-1BBL promoted survival of CD4 and CD8 T cells, particularly at late stages of the MLR. CD4 and CD8 T cells both responded to anti-CD3 plus s4-1BBL with a similar cytokine profile as observed in the MLR. CD4 and CD8 T cells exhibited enhanced proliferation and earlier cell division when stimulated with anti-CD3 plus anti-CD28 compared with anti-CD3 plus 4-1BBL, and both subsets responded comparably to anti-CD3 plus 4-1BBL. These data support the idea that CD28 plays a primary role in initial T cell expansion, whereas 4-1BB/4-1BBL sustains both CD4 and CD8 T cell responses, as well as enhances cell division and T cell effector function.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Sabbagh, G. Pulle, Y. Liu, E. N. Tsitsikov, and T. H. Watts
ERK-Dependent Bim Modulation Downstream of the 4-1BB-TRAF1 Signaling Axis Is a Critical Mediator of CD8 T Cell Survival In Vivo
J. Immunol., June 15, 2008; 180(12): 8093 - 8101.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Habib-Agahi, T. T. Phan, and P. F. Searle
Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells
Int. Immunol., December 1, 2007; 19(12): 1383 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. H. Yi, H. Nechushtan, W. J. Bowers, G. R. Walker, Y. Zhang, D. G. Pham, E. R. Podack, H. J. Federoff, K. A. Tolba, and J. D. Rosenblatt
Adoptively Transferred Tumor-Specific T Cells Stimulated Ex vivo Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity In vivo
Cancer Res., October 15, 2007; 67(20): 10027 - 10037.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Zhang, K. M. Snyder, M. M. Suhoski, M. V. Maus, V. Kapoor, C. H. June, and C. L. Mackall
4-1BB Is Superior to CD28 Costimulation for Generating CD8+ Cytotoxic Lymphocytes for Adoptive Immunotherapy
J. Immunol., October 1, 2007; 179(7): 4910 - 4918.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Brentjens, E. Santos, Y. Nikhamin, R. Yeh, M. Matsushita, K. La Perle, A. Quintas-Cardama, S. M. Larson, and M. Sadelain
Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts
Clin. Cancer Res., September 15, 2007; 13(18): 5426 - 5435.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-J. Lee, R. J. Rossi, S.-K. Lee, M. Croft, B. S. Kwon, R. S. Mittler, and A. T. Vella
CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent
J. Immunol., August 15, 2007; 179(4): 2203 - 2214.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Wolfl, J. Kuball, W. Y. Ho, H. Nguyen, T. J. Manley, M. Bleakley, and P. D. Greenberg
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Blood, July 1, 2007; 110(1): 201 - 210.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. F. van Oosterwijk, H. Juwana, R. Arens, K. Tesselaar, M. H.J. van Oers, E. Eldering, and R. A.W. van Lier
CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development
Int. Immunol., June 4, 2007; (2007) dxm033v1.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. Shin, Y. H. Kim, B. K. Choi, P. M. Kwon, H.-W. Lee, and B. S. Kwon
4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation
J. Leukoc. Biol., June 1, 2007; 81(6): 1455 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Zhang, R. E. Sadun, R. S. Arias, M. L. Flanagan, S. M. Sachsman, Y.-C. Nien, L. A. Khawli, P. Hu, and A. L. Epstein
Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors
Clin. Cancer Res., May 1, 2007; 13(9): 2758 - 2767.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Irie, Y. Wu, K. Kachapati, R. S. Mittler, and W. M. Ridgway
Modulating Protective and Pathogenic CD4+ Subsets via CD137 in Type 1 Diabetes
Diabetes, January 1, 2007; 56(1): 186 - 196.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Carr, M. J. Carrasco, J. E. D. Thaventhiran, P. J. Bambrough, M. Kraman, A. D. Edwards, A. Al-Shamkhani, and D. T. Fearon
CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation
PNAS, December 19, 2006; 103(51): 19454 - 19459.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-W. Lee, Y. Park, A. Song, H. Cheroutre, B. S. Kwon, and M. Croft
Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses
J. Immunol., October 1, 2006; 177(7): 4464 - 4472.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Stasiolek, A. Bayas, N. Kruse, A. Wieczarkowiecz, K. V. Toyka, R. Gold, and K. Selmaj
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis
Brain, May 1, 2006; 129(5): 1293 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Pulle, M. Vidric, and T. H. Watts
IL-15-Dependent Induction of 4-1BB Promotes Antigen-Independent CD8 Memory T Cell Survival.
J. Immunol., March 1, 2006; 176(5): 2739 - 2748.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. Myers, S. W. Lee, R. J. Rossi, L. Lefrancois, B. S. Kwon, R. S. Mittler, M. Croft, and A. T. Vella
Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells
Int. Immunol., February 1, 2006; 18(2): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Rabu, A. Quemener, Y. Jacques, K. Echasserieau, P. Vusio, and F. Lang
Production of Recombinant Human Trimeric CD137L (4-1BBL): CROSS-LINKING IS ESSENTIAL TO ITS T CELL CO-STIMULATION ACTIVITY
J. Biol. Chem., December 16, 2005; 280(50): 41472 - 41481.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Vidric, W.-K. Suh, U. Dianzani, T. W. Mak, and T. H. Watts
Cooperation between 4-1BB and ICOS in the Immune Response to Influenza Virus Revealed by Studies of CD28/ICOS-Deficient Mice
J. Immunol., December 1, 2005; 175(11): 7288 - 7296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Serghides, J. Bukczynski, T. Wen, C. Wang, J.-P. Routy, M.-R. Boulassel, R.-P. Sekaly, M. Ostrowski, N. F. Bernard, and T. H. Watts
Evaluation of OX40 Ligand as a Costimulator of Human Antiviral Memory CD8 T Cell Responses: Comparison with B7.1 and 4-1BBL
J. Immunol., November 15, 2005; 175(10): 6368 - 6377.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S.-C. Lee, S.-A. Ju, H.-N. Pack, S.-K. Heo, J.-H. Suh, S.-M. Park, B.-K. Choi, B. S. Kwon, and B. S. Kim
4-1BB (CD137) Is Required for Rapid Clearance of Listeria monocytogenes Infection
Infect. Immun., August 1, 2005; 73(8): 5144 - 5151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Myers, M. Croft, B. S. Kwon, R. S. Mittler, and A. T. Vella
Peptide-Specific CD8 T Regulatory Cells Use IFN-{gamma} to Elaborate TGF-{beta}-Based Suppression
J. Immunol., June 15, 2005; 174(12): 7625 - 7632.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-W. Lee, A. T. Vella, B. S. Kwon, and M. Croft
Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB
J. Immunol., June 1, 2005; 174(11): 6803 - 6808.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. E. Comer, C. L. Galindo, A. K. Chopra, and J. W. Peterson
GeneChip Analyses of Global Transcriptional Responses of Murine Macrophages to the Lethal Toxin of Bacillus anthracis
Infect. Immun., March 1, 2005; 73(3): 1879 - 1885.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Kim, W. S. Choi, S. La, J.-H. Suh, B.-S. Kim, H. R. Cho, B. S. Kwon, and B. Kwon
Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells
Blood, March 1, 2005; 105(5): 2206 - 2213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-O. Nam, H. Kang, S.-M. Shin, K.-H. Cho, B. Kwon, B. S. Kwon, S.-J. Kim, and H.-W. Lee
Cross-Linking of 4-1BB Activates TCR-Signaling Pathways in CD8+ T Lymphocytes
J. Immunol., February 15, 2005; 174(4): 1898 - 1905.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Shao, Y. Fu, T. Liao, Y. Peng, L. Chen, H. J. Kaplan, and D. Sun
Anti-CD137 mAb Treatment Inhibits Experimental Autoimmune Uveitis by Limiting Expansion and Increasing Apoptotic Death of Uveitogenic T Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 596 - 603.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Taneja, N. Taneja, M. Behrens, M. M. Griffiths, H. S. Luthra, and C. S. David
Requirement for CD28 May Not Be Absolute for Collagen-Induced Arthritis: Study with HLA-DQ8 Transgenic Mice
J. Immunol., January 15, 2005; 174(2): 1118 - 1125.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
I. PRIGIONE, M. V. CORRIAS, I. AIROLDI, L. RAFFAGHELLO, F. MORANDI, P. BOCCA, C. COCCO, S. FERRONE, and V. PISTOIA
Immunogenicity of Human Neuroblastoma
Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 69 - 80.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Ito, Q. Li, A. B. Shreiner, R. Okuyama, M. N. Jure-Kunkel, S. Teitz-Tennenbaum, and A. E. Chang
Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines
Cancer Res., November 15, 2004; 64(22): 8411 - 8419.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Dawicki, E. M. Bertram, A. H. Sharpe, and T. H. Watts
4-1BB and OX40 Act Independently to Facilitate Robust CD8 and CD4 Recall Responses
J. Immunol., November 15, 2004; 173(10): 5944 - 5951.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Florido, M. Borges, H. Yagita, and R. Appelberg
Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium
J. Leukoc. Biol., November 1, 2004; 76(5): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. L. Galindo, A. A. Fadl, J. Sha, and A. K. Chopra
Microarray Analysis of Aeromonas hydrophila Cytotoxic Enterotoxin-Treated Murine Primary Macrophages
Infect. Immun., September 1, 2004; 72(9): 5439 - 5445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Teague, R. M. Tempero, S. Thomas, K. Murali-Krishna, and B. H. Nelson
Proliferation and Differentiation of CD8+ T Cells in the Absence of IL-2/15 Receptor {beta}-Chain Expression or STAT5 Activation
J. Immunol., September 1, 2004; 173(5): 3131 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Carrio, O. F. Bathe, and T. R. Malek
Initial Antigen Encounter Programs CD8+ T Cells Competent to Develop into Memory Cells That Are Activated in an Antigen-Free, IL-7- and IL-15-Rich Environment
J. Immunol., June 15, 2004; 172(12): 7315 - 7323.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Lathrop, C. A. Huddleston, P. A. Dullforce, M. J. Montfort, A. D. Weinberg, and D. C. Parker
A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions
J. Immunol., June 1, 2004; 172(11): 6735 - 6743.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. K. Choi, J. S. Bae, E. M. Choi, W. J. Kang, S. Sakaguchi, D. S. Vinay, and B. S. Kwon
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells
J. Leukoc. Biol., May 1, 2004; 75(5): 785 - 791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Saito, N. Ohara, H. Hotokezaka, S. Fukumoto, K. Yuasa, M. Naito, T. Fujiwara, and K. Nakayama
Infection-induced Up-regulation of the Costimulatory Molecule 4-1BB in Osteoblastic Cells and Its Inhibitory Effect on M-CSF/RANKL-induced in Vitro Osteoclastogenesis
J. Biol. Chem., April 2, 2004; 279(14): 13555 - 13563.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Bukczynski, T. Wen, K. Ellefsen, J. Gauldie, and T. H. Watts
Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses
PNAS, February 3, 2004; 101(5): 1291 - 1296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, F. Amanullah, R. Kewalaramani, H. Yagita, T. B. Strom, M. H. Sayegh, and X. C. Li
Critical Role of OX40 in CD28 and CD154-Independent Rejection
J. Immunol., February 1, 2004; 172(3): 1691 - 1698.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M. Bertram, W. Dawicki, B. Sedgmen, J. L. Bramson, D. H. Lynch, and T. H. Watts
A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo
J. Immunol., January 15, 2004; 172(2): 981 - 988.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. Wilcox, K. Tamada, D. B. Flies, G. Zhu, A. I. Chapoval, B. R. Blazar, W. M. Kast, and L. Chen
Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo
Blood, January 1, 2004; 103(1): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Wiethe, K. Dittmar, T. Doan, W. Lindenmaier, and R. Tindle
Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-{kappa}B (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen
J. Immunol., October 15, 2003; 171(8): 4121 - 4130.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. L. Disis, N. Scholler, A. Dahlin, J. Pullman, K. L. Knutson, K.-E. Hellstrom, and I. Hellstrom
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity
Mol. Cancer Ther., October 1, 2003; 2(10): 995 - 1002.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Myers, C. Takahashi, R. S. Mittler, R. J. Rossi, and A. T. Vella
Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering
PNAS, April 29, 2003; 100(9): 5348 - 5353.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Wiethe, K. Dittmar, T. Doan, W. Lindenmaier, and R. Tindle
Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen
J. Immunol., March 15, 2003; 170(6): 2912 - 2922.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. J. Shedlock, J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen
Role of CD4 T Cell Help and Costimulation in CD8 T Cell Responses During Listeria monocytogenes Infection
J. Immunol., February 15, 2003; 170(4): 2053 - 2063.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
L E Schiffer, N Hussain, X Wang, W Huang, J Sinha, M Ramanujam, and A Davidson
Lowering anti-dsDNA antibodies--what's new?
Lupus, December 1, 2002; 11(12): 885 - 894.
[Abstract] [PDF]


Home page
J. Immunol.Home page
P. Bansal-Pakala and M. Croft
Defective T Cell Priming Associated with Aging Can Be Rescued by Signaling Through 4-1BB (CD137)
J. Immunol., November 1, 2002; 169(9): 5005 - 5009.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-J. Kim, R. R. Brutkiewicz, and H. E. Broxmeyer
Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
Blood, October 16, 2002; 100(9): 3253 - 3260.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Wilcox, K. Tamada, S. E. Strome, and L. Chen
Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity
J. Immunol., October 15, 2002; 169(8): 4230 - 4236.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Laderach, M. Movassagh, A. Johnson, R. S. Mittler, and A. Galy
4-1BB co-stimulation enhances human CD8+ T cell priming by augmenting the proliferation and survival of effector CD8+ T cells
Int. Immunol., October 1, 2002; 14(10): 1155 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Lindstedt, B. Johansson-Lindbom, and C. A. K. Borrebaeck
Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators
Int. Immunol., October 1, 2002; 14(10): 1203 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Cannons, E. M. Bertram, and T. H. Watts
Cutting Edge: Profound Defect in T Cell Responses in TNF Receptor-Associated Factor 2 Dominant Negative Mice
J. Immunol., September 15, 2002; 169(6): 2828 - 2831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. W. Chan, C. D. Hopke, S. M. Krams, and O. M. Martinez
CD30 Expression Identifies the Predominant Proliferating T Lymphocyte Population in Human Alloimmune Responses
J. Immunol., August 15, 2002; 169(4): 1784 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Wilcox, D. B. Flies, H. Wang, K. Tamada, A. J. Johnson, L. R. Pease, M. Rodriguez, Y. Guo, and L. Chen
Impaired Infiltration of Tumor-specific Cytolytic T Cells in the Absence of Interferon-{gamma} despite Their Normal Maturation in Lymphoid Organs during CD137 Monoclonal Antibody Therapy
Cancer Res., August 1, 2002; 62(15): 4413 - 4418.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Tarrant, J. Groom, D. Metcalf, R. Li, B. Borobokas, M. D. Wright, D. Tarlinton, and L. Robb
The Absence of Tssc6, a Member of the Tetraspanin Superfamily, Does Not Affect Lymphoid Development but Enhances In Vitro T-Cell Proliferative Responses
Mol. Cell. Biol., July 15, 2002; 22(14): 5006 - 5018.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Cappellen, N.-H. Luong-Nguyen, S. Bongiovanni, O. Grenet, C. Wanke, and M. Susa
Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFkappa B
J. Biol. Chem., June 7, 2002; 277(24): 21971 - 21982.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. F. May Jr., L. Chen, P. Zheng, and Y. Liu
Anti-4-1BB Monoclonal Antibody Enhances Rejection of Large Tumor Burden by Promoting Survival but not Clonal Expansion of Tumor-specific CD8+ T Cells
Cancer Res., June 1, 2002; 62(12): 3459 - 3465.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Wen, J. Bukczynski, and T. H. Watts
4-1BB Ligand-Mediated Costimulation of Human T Cells Induces CD4 and CD8 T Cell Expansion, Cytokine Production, and the Development of Cytolytic Effector Function
J. Immunol., May 15, 2002; 168(10): 4897 - 4906.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Wilcox, A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K